NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,802.80+₹41.80 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
Loading market information…
NSE · JAGSNPHARM.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Jagsonpal Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 17.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Jagsonpal Pharmaceuticals Limited’s forward annual dividend is ₹4.00 per share, paid annual. The forward yield is 1.84% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Jagsonpal Pharmaceuticals Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Jagsonpal Pharmaceuticals Limited, an Indian company founded in 1964 and based in New Delhi, specializes in the development and manufacturing of both bulk active pharmaceutical ingredients and diverse medicinal formulations. Its product portfolio spans three primary therapeutic domains: women's health, pain management and analgesia, and general medical care. Within general medicine, the company offers solutions for allergy control, immune and cellular protection, gastrointestinal and mental wellness, anti-infectives, and products specifically for dental and ear, nose, and throat (ENT) conditions. For women's healthcare, their offerings include pregnancy support and treatments for issues related to dysfunctional uterine bleeding. Furthermore, Jagsonpal provides medications for pain relief and skeletal and joint health. These pharmaceutical items are supplied in common forms like tablets, capsules, and syrups. The company operates as a subsidiary under Aresko Progressive Private Limited.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,802.80+₹41.80 (+2.37%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.96% below the high.
₹9,734.00+₹70.00 (+0.72%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
₹886.00-₹35.10 (-3.81%)
Sigma Advanced Systems Limited’s quoted price sits in the upper half of its reported 52-week range, 23.61% below the high.
₹646.90-₹34.00 (-4.99%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.74% below the high.
₹2,287.00-₹20.60 (-0.89%)
Hester Biosciences Limited’s quoted price sits in the upper half of its reported 52-week range, 14.78% below the high.
₹19.47-₹0.94 (-4.61%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.1% below the high.
₹305.00-₹7.85 (-2.51%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.55% below the high.
₹26.38-₹0.22 (-0.83%)
Sigachi Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 35.34% below the high.
